Press Releases
- Sangart Raises Additional $50M Series G Funding Following Interim Safety Analysis Of Phase 2b Study Of MP4OX In Severe Trauma Patients With Hemorrhagic Shock
- Lucigen Corporation Awarded $2.8M SBIR Grant for Point of Care Diagnostics
- Blueprint Medicines Welcomes Fidelity Biosciences to Investor Syndicate
- Veloxis Pharmaceuticals announces a restructuring of the company to support and strengthen strategic focus on LCP-Tacro(TM) and announces changes to management
- Celldex's CDX-011 Demonstrates High Response Rates in Patients with Metastatic Breast Cancer Expressing Elevated Levels of GPNMB and in Triple Negative Disease
- More Press Releases


